Blog Post from Salt Institute
Socialized (junk) science
June 20, 2008
Written by: Dick Hanneman
Health and nutrition activists are attempting to demonize all science not funded by (friendly) government bureaucrats. This leads, inevitably and quickly, to politically-correct junk science.
A related theme is voiced in an op ed piece from earlier this week in the Financial Post, part of the National Post, one of Canda's largest papers.
Author Dr. Beth Whelan, president of NYC-based American Council for Science and Health, decries "the witch hunt against corporate funding of research," pointing out several recent example of how Health Canada has embraced junk science in order to address alleged health threats. She explains that the
latest unscientific legislation (was) made possible in part by a dangerous prevailing assumption: namely, that anti-corporate claims are by definition "good science" while claims made in defence of industry or new technology -- by anyone with the slightest ties to industry -- are by definition "suspect science."
She continues:
Ironically, consumers end up paying higher prices as a result of such ostensibly consumer-protecting measures (as products need to be replaced or reformulated) or even end up using less-safe replacement products, such as old-fashioned glass bottles.
Because the insidious de-legitimizing has progressed so far, she laments:
CSPI and others, ignoring decades of productive collaboration between industry and science, can now delegitimize any scientist or scientific conclusion with which they disagree by showing that the scientist or research in question is tied to corporate money.
Our beef is the other side of this coin, namely that the converse of uncritically rejecting any privately-funded research as biased is the uncritical acceptance of publicly-funded research as immune from bias since its sponsors are public agencies. We've seen too many examples of government cooking the books and funding scientists who refuse to divulge their data for independent expert verification.
Economists well understand the perverse incentives that apply when government insists on owning the means of production. Will the public -- and public health practioners themselves -- recognize the perverse incentives inherent in the uncritical acceptance of junk science based on the supposedly-untainted funding from public agencies?
Tags
Share this page
1 Comments
Leave a comment
Who's Blogging
- American Petroleum Institute
- American Trucking Associations
- Business Roundtable
- CTIA - The Wireless Association
- National Association of Chain Drug Stores
- National Electrical Manufacturers Association
- Nuclear Energy Institute
- Organization for International Investment
- Pat Cleary
- Personal Care Products Council
- Salt Institute
- USTelecom
Recent Posts
- "Salt: the ultimate medicinal vehicle": American Geological Institute
07/02/2008 - Socialized (junk) science
06/20/2008 - Good news is no(t) news
06/13/2008 - Salt iodization, ending "hidden hunger," free trade are top ROI public health investments
05/30/2008 - Czech president could have been speaking about salt
05/28/2008


An interesting post. On this side of the Atlantic we share some of the same issues but with an extra twist. We of course recently created REACH (our new chemicals regulation), which places the burden of proof formerly on the producer/importer of the chemical. Tests, paid for by industry, are in effect mandated by legislation.
Having said this, REACH has not stopped some questionning the validity of industry funded work, or indeed the uncritical acceptance of junk science. Nevertheless, at least those that came up with REACH are willing to defend the principles behind it and their results.
A recent response by the European Commission to a parliamentary question from a German Green Member of the European Parliament underlined that at least on this question our regulators are following the right path:
"It is the task of EFSA [the relevant scientific body] to scrutinise the scientific soundness of the studies it is taking into account, i.e.if it is appropriately designed and if it is performed according to GLP. The specific interest of the group who financed it should not be a criterion for accepting or rejecting a study."